An atlas of active enhancers across human cell types and tissues
Open accessThe DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.
Abstract
Enhancers control the correct temporal and cell-type-specific activation of gene expression in multicellular eukaryotes. Knowing their properties, regulatory activity and targets is crucial to understand the regulation of differentiation and homeostasis. Here we use the FANTOM5 panel of samples, covering the majority of human tissues and cell types, to produce an atlas of active, in vivo-transcribed enhancers. We show that enhancers share properties with CpG-poor messenger RNA promoters but produce bidirectional, exosome-sensitive, relatively short unspliced RNAs, the generation of which is strongly related to enhancer activity. The atlas is used to compare regulatory programs between different cells at unprecedented depth, to identify disease-associated regulatory single nucleotide polymorphisms, and to classify cell-type-specific and ubiquitous enhancers. We further explore the utility of enhancer redundancy, which explains gene expression strength rather than expression patterns. The online FANTOM5 enhancer atlas represents a unique resource for studies on cell-type-specific enhancers and gene regulation. Using the FANTOM5 CAGE expression atlas, the authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify over 40,000 enhancer candidates from over 800 human cell and tissue samples across the whole human body. FANTOM5 (standing for functional annotation of the mammalian genome 5) is the fifth major stage of a major international collaboration that aims to dissect the transcriptional regulatory networks that define every human cell type. Two Articles in this issue of Nature present some of the project's latest results. The first paper uses the FANTOM5 panel of tissue and primary cell samples to define an atlas of active, in vivo bidirectionally transcribed enhancers across the human body. These authors show that bidirectional capped RNAs are a signature feature of active enhancers and identify more than 40,000 enhancer candidates from over 800 human cell and tissue samples. The enhancer atlas is used to compare regulatory programs between different cell types and identify disease-associated regulatory SNPs, and will be a resource for studies on cell-type-specific enhancers. In the second paper, single-molecule sequencing is used to map human and mouse transcription start sites and their usage in a panel of distinct human and mouse primary cells, cell lines and tissues to produce the most comprehensive mammalian gene expression atlas to date. The data provide a plethora of insights into open reading frames and promoters across different cell types in addition to valuable annotation of mammalian cell-type-specific transcriptomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although enriched, histone modification and cofactor binding is not completely predictive of enhancer activity54,58,72,77,105.”
From Towards a comprehensive catalogue of validated and target-linked human enhancers (2020) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The majority of active enhancers are themselves transcribed, producing enhancer RNAs (eRNAs) in a bi-directional manner [73–77].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of their sequence properties, enhancers and promoters tend to differ in GC content, with many promoters and only a subset of enhancers containing CpG islands [74, 249].”
From Transcriptional enhancers and their communication with gene promoters (2021) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“We filtered intragenic CAGE TCs with GG-initiation and those overlapping with coding exons and annotated enhancers24,70”
From Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes (2023) · cites this paper as [24]
In the citing paper
“as regulatory elements are subject to positive selection pressure, we identified sequences showing the highest conservation across mammalian species, including humans25–29.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382 · cited 1×
“These were grouped according to Hela-S3 expression tertiles: low (36), mid-level (41) and strong (46).”
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Cited by
Items 901–1,000 of 1,017
Intragenic CpG islands play important roles in bivalent chromatin assembly of developmental genes
Lee, S.-M., Lee, J., Noh, K.-M., Choi, W.-Y., Jeon, S., Oh, G. T., Kim‐Ha, J., Jin, Y., Cho, S., & Kim, Y.-J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613300114 · Cited by 38
Bush, S. J., McCulloch, M. E. B., SUMMERS, K. M., Hume, D. A., & Clark, E. L. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1714-9 · Cited by 38
“The FANTOM5 consortium produced comprehensive expression atlases for mouse and human based upon tag sequencing of 5 ′ ends (cap analysis gene expression; CAGE) [48, 49].”
MethodSelf-citationA survey of recently emerged genome-wide computational enhancer predictor tools
Lim, L. W. K., Chung, H. H., Chong, Y. L., & Lee, N. K. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.03.019 · Cited by 41
A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics
Su, Y., Di, C., Bien, S. A., Huang, L., Dong, X., Abecasis, G. R., Berndt, S. I., Bezieau, S., Brenner, H., Caan, B. J., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.019 · Cited by 38
Determinants of promoter and enhancer transcription directionality in metazoans
Ibrahim, M. M., Calviello, A. K., Glahs, A., Kolundžić, E., Hirsekorn, A., Carda, A., Tursun, B., Zinzen, R. P., Lacadie, S. A., & Ohler, U. (2018) · Nature Communications · doi:10.1038/s41467-018-06962-z · Cited by 40
Merlin, S., Famà, R., Borroni, E., Zanolini, D., Bruscaggin, V., Zucchelli, S., & Follenzi, A. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018027979 · Cited by 33
Short DNA sequence patterns accurately identify broadly active human enhancers
Colbran, L. L., Chen, L., & Capra, J. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3934-9 · Cited by 33
“We considered 38,538 transcribed enhancers identified via CAGE for 411 contexts by the FANTOM consortium [13].”
MethodAffinity-Based Profiling of the Flavin Mononucleotide Riboswitch
Crielaard, S., Maassen, R., Vosman, T., Rempkens, I., & Velema, W. A. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02685 · Cited by 35
Rare and low-frequency variants in human common diseases and other complex traits
Lettre, G. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102437 · Cited by 43
Identifying transcription start sites and active enhancer elements using BruUV-seq
Magnuson, B., Veloso, A., Kirkconnell, K. S., Lima, L. C. D. A., Paulsen, M. T., Ljungman, E. A., Bedi, K., Prasad, J., Wilson, T. E., & Ljungman, M. E. (2015) · Scientific Reports · doi:10.1038/srep17978 · Cited by 37
Kawakami, E., Nakaoka, S., Ohta, T., & Kitano, H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw355 · Cited by 34
“Recently a genome-wide atlas of enhancers was constructed covering the majority of tissues and cell types of human and mouse (43,44).”
BackgroundRoudnicky, F., Dieterich, L. C., Poyet, C., Buser, L., Wild, P. J., Tang, D. T. P., Camenzind, P., Ho, C. H., Otto, V. I., & Detmar, M. J. (2017) · The Journal of Pathology · doi:10.1002/path.4892 · Cited by 35
The RNA Polymerase II Factor RPAP1 Is Critical for Mediator-Driven Transcription and Cell Identity
Lynch, C. J., Bernad, R., Calvo, I., Pereira, S. N., Ruiz, S., Ibarz, N., Martínez‐Val, A., Graña‐Castro, O., Goméz-López, G., Andrés‐León, E., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.062 · Cited by 35
“Expression levels of enhancer RNAs (eRNAs) are proportional to their enhancer activity (Andersson et al., 2014; Li et al., 2016).”
BackgroundPsip1/p52 regulates posterior Hoxa genes through activation of lncRNA Hottip
Pradeepa, M. M., McKenna, F., Taylor, G. C. A., Bengani, H., Grimes, G. R., Wood, A. J., Bhatia, S., & Bickmore, W. A. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006677 · Cited by 34
Tammimies, K., Bieder, A., Lauter, G., Sugiaman‐Trapman, D., Torchet, R., Hokkanen, M., Burghoorn, J., Ċastrén, E., Kere, J., Tapia‐Páez, I., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500124rr · Cited by 38
“In recent years, increased interest has focused on understanding the functional elements in the noncoding parts of thegenome, as exemplifiedby theEncyclopedia of DNA Elements (60) and Functional Annotation of the HumanGenome (61, 62)projects.”
BackgroundPast Roadblocks and New Opportunities in Transcription Factor Network Mapping
Brent, M. R. (2016) · Trends in Genetics · doi:10.1016/j.tig.2016.08.009 · Cited by 44
“This is reported to result in assignment of 40%of enhancers to the nearest TSS and 64% to a TSSwithin 500 kb [58].”
InfluentialER-positive breast cancer cells are poised for RET-mediated endocrine resistance
Horibata, S., Rice, E. J., Mukai, C., Marks, B. A., Sams, K. L., Zheng, H., Anguish, L. J., Coonrod, S. A., & Danko, C. G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194023 · Cited by 38
A neural network based model effectively predicts enhancers from clinical ATAC-seq samples
Thibodeau, A., Uyar, A., Khetan, S., Stitzel, M. L., & Ucar, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-34420-9 · Cited by 37
Histone H3 lysine 4 methylation signature associated with human undernutrition
Uchiyama, R., Kupkova, K., Shetty, S. J., Linford, A. S., Pray-Grant, M. G., Wagar, L. E., Davis, M. M., Haque, R., Gaultier, A., Mayo, M. W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722125115 · Cited by 36
“Thus, the biological role of KDM5C is consistent with it contributing to the observed shift in methylation away from TSSs and to distal sites, including regulatory regions.”
InfluentialBresnick, E. H., & Johnson, K. D. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000378 · Cited by 34
Inferring the Molecular Mechanisms of Noncoding Alzheimer’s Disease-Associated Genetic Variants
Amlie‐Wolf, A., Tang, M., Way, J., Dombroski, B. A., Ming, J., Vrettos, N., Chou, Y., Zhao, Y., Kuzma, A. B., Mlynarski, E. E., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190568 · Cited by 33
Barešić, A., Nash, A. J., Dahoun, T., Howes, O. D., & Lenhard, B. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0518-x · Cited by 35
Developmental Transcriptional Enhancers: A Subtle Interplay between Accessibility and Activity
Bozek, M., & Gompel, N. (2020) · BioEssays · doi:10.1002/bies.201900188 · Cited by 37
Ullastres, A., Merenciano, M., & González, J. (2021) · Genome biology · doi:10.1186/s13059-021-02471-3 · Cited by 38
Sun, Y.-H., Sedgwick, A. J., Khan, M. A.-A.-K., Palarasah, Y., Mangiola, S., & Barrow, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.724107 · Cited by 31
“(56), PRJNA339309 (57), GSE122325 (58), FANTOM5 (59), GSE125887 (60), GSE130379 (61), and GSE130286 (62).”
Giacopuzzi, E., Popitsch, N. P., & Taylor, J. C. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac130 · Cited by 33
“Main functional elements in the human genome, such as enhancers, promoters, and TF binding sites, have been extensively mapped by large international collaborations like ENCODE (17,18) and FANTOM5 (19,20).”
Quality-controlled R-loop meta-analysis reveals the characteristics of R-loop consensus regions
Miller, H. E., Montemayor, D., Abdul, J., Vines, A., Levy, S. A., Hartono, S. R., Sharma, K., Frost, B. E., Chedin, F. L., & Bishop, A. J. R. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac537 · Cited by 29
“Previous reports have shown that eRNAs are smaller than most lncRNA species, being ∼350 nucleotides in length on average (91).”
BackgroundTranscriptional Regulation and Macrophage Differentiation
Hume, D. A., SUMMERS, K. M., & Rehli, M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0024-2015 · Cited by 37
Self-citationWang, L. Q., Wong, K. Y., Li, Z. H., & Chim, C. S. (2016) · Oncotarget · doi:10.18632/oncotarget.12252 · Cited by 36
“Indeed, recent studies showed that lncRNAs could regulate the expression of neighboring genes in cis or trans [25, 33].”
BackgroundInsight into origins, mechanisms, and utility of DNA methylation in B-cell malignancies
Oakes, C. C., & Martín-Subero, J. I. (2018) · Blood · doi:10.1182/blood-2018-02-692970 · Cited by 37
Transcriptional Profiling of Hypoxia-Regulated Non-coding RNAs in Human Primary Endothelial Cells
Moreau, P. R., Örd, T., Downes, N. L., Niskanen, H., Bouvy‐Liivrand, M., Aavik, E., Ylä‐Herttuala, S., & Kaikkonen, M. U. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00159 · Cited by 35
“In line with their genomic origin, p-lncRNAs revealed enrichment for motifs known to be promoter-proximal, such as binding motifs for Sp1 and NRF1 (56, 57).”
BackgroundTargeting the host immune response to fight infection
Baillie, J. K. (2014) · Science · doi:10.1126/science.1255074 · Cited by 36
Self-citationCornish, A. J., Filippis, I., David, A., & Sternberg, M. J. E. (2015) · Genome Medicine · doi:10.1186/s13073-015-0212-9 · Cited by 34
“further organized these groups into broader facets, based upon cell function and morphology [9].”
BackgroundMethodInfluentialRamirez, M., Badayeva, Y., Yeung, J., Wu, J., Abdalla-Wyse, A., Yang, E., Trost, B., Scherer, S. W., & Goldowitz, D. (2022) · eLife · doi:10.7554/elife.74207 · Cited by 48
“Previous genome-wide and locus-specific functional studies have shown evidence of enhancers with activity in multiple developmental contexts ( Singh and Yi, 2021 ; Preger-Ben Noon et al., 2018 ; Lonfat et al., 2014 ; Andersson et al., 2014 ; Nord et al., 2013 ; Hiller et al., 2012 ).”
Weber, A., Schwarz, S. C., Tost, J., Trümbach, D., Winter, P., Busato, F., Tacik, P. M., Windhorst, A., Fagny, M., Arzberger, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05325-y · Cited by 33
Tolza, C., Bejjani, F., Evanno, E., Mahfoud, S., Moquet-Torcy, G., Gostan, T., Maqbool, M. A., Kirsh, O., Piechaczyk, M., & Jariel‐Encontre, I. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0036 · Cited by 32
“They are often referred as a single entity due to their high sequence homology and functional similarity (59) and have been described to be part of active enhancer signatures (56, 60).”
BackgroundSrivastava, A., Kumar, A., Giangiobbe, S., Bonora, E., Hemminki, K., Försti, A., & Bandapalli, O. R. (2019) · Biomolecules · doi:10.3390/biom9100605 · Cited by 32
CRUP: a comprehensive framework to predict condition-specific regulatory units
Ramisch, A., Heinrich, V., Glaser, L. V., Fuchs, A., Yang, X., Benner, P., Schöpflin, R., Li, N., Kinkley, S., Römer-Hillmann, A., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1860-7 · Cited by 31
“The enhancers used for testing (as for training) are based on regions defined by the FANTOM5 project [36] and are chosen and curated as described in the “Definition of high-confidence enhancer regions” section.”
MethodPAN RNA: transcriptional exhaust from a viral engine
Campbell, M., & Izumiya, Y. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00637-y · Cited by 28
LncRNA Platr22 promotes super-enhancer activity and stem cell pluripotency
Yan, P., Lu, J. Y., Niu, J., Gao, J. T., Zhang, M. Q., Yin, Y., & Shen, X. (2020) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjaa056 · Cited by 34
“Introduction Enhancers are cis-regulatory DNA regions that positively control the activity of promoters in a cell type- or tissue-specific manner (Andersson et al., 2014; Li et al., 2016).”
BackgroundMachine learning methods to model multicellular complexity and tissue specificity
Sealfon, R. S. G., Wong, A. K., & Troyanskaya, O. G. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00339-3 · Cited by 32
Complex small-world regulatory networks emerge from the 3D organisation of the human genome
Brackley, C. A., Gilbert, N., Michieletto, D., Papantonis, A., Pereira, M. C. F., Cook, P. R., & Marenduzzo, D. (2021) · Nature Communications · doi:10.1038/s41467-021-25875-y · Cited by 38
“Perhaps surprisingly, these are rarely found in genes encoding transcription factors or other proteins; instead, they usually involve single-nucleotide changes in non-coding elements that bind transcription factors such as active enhancers and promoters 8 – 10 .”
BackgroundGordillo‐Marañón, M., Zwierzyna, M., Charoen, P., Drenos, F., Chopade, S., Shah, T., Engmann, J., Casas, J. P., Chaturvedi, N., Papacosta, O., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25731-z · Cited by 35
“For each included gene and tissue, HPA provides a consensus Normalized eXpression value (NX), obtained by normalizing TPM (transcripts per million) values from three independent transcriptomics datasets: GTEx (55), Fantom5 (56), and HPA’s own RNAseq experiments (57).”
Non‐coding regulatory elements: Potential roles in disease and the case of epilepsy
Pagni, S., Mills, J. D., Frankish, A., Mudge, J. M., & Sisodiya, S. M. (2021) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12775 · Cited by 40
“Examples include the Encyclope-dia of DNA Elements (ENCODE database), the Functional Annotation of the Mammalian Genome project (FANTOM5), the PsychENCODE Consortium and the machine learning tool RefMap [83, 84].”
Classification of non-coding variants with high pathogenic impact
Moyon, L., Berthelot, C., Louis, A., Nguyen, N. T. T., & Crollius, H. R. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010191 · Cited by 36
“4, accessed 2018-12-17), PEGASUS [20] (2018-12-17), FANTOM5 co-expressed regions [16] (2018-11-19), FOCS FANTOM5, FOCS ROADMAP DHS, and FOCS Gro-seq co-expression [17] (2018-12-11).”
BackgroundMethodInfluentialPre-neoplastic epigenetic disruption of transcriptional enhancers in chronic inflammation
Planello, A. C., Singhania, R., Kron, K. J., Bailey, S. D., Roulois, D., Lupien, M., Line, S. R. P., de Souza, A. P., & Carvalho, D. D. D. (2016) · Oncotarget · doi:10.18632/oncotarget.7513 · Cited by 32
“These active enhancers were called based on bi-directional transcription in CAGE-seq data [28].”
BackgroundMethodInfluentialShilpi, A., Bi, Y., Jung, S. C., Patra, S. K., & Davuluri, R. V. (2017) · Cancer Informatics · doi:10.4137/cin.s39783 · Cited by 35
Laverré, A., Tannier, É., & Necşulea, A. (2021) · Genome Research · doi:10.1101/gr.275901.121 · Cited by 38
García-Cabezas, M. Á., Barbas, H., & Zikopoulos, B. (2018) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2018.00070 · Cited by 30
An overview of artificial intelligence in the field of genomics
Maqsood, K., Hagras, H., & Zabet, N. R. (2024) · Discover Artificial Intelligence · doi:10.1007/s44163-024-00103-w · Cited by 39
“Furthermore, there is no specific motif or code for enhancers, and they may only be active in specific temporal, environmental, and spatial conditions [3].”
SWI/SNF-dependent genes are defined by their chromatin landscape
Basurto-Cayuela, L., Guerrero-Martinez, J. A., Gómez-Marín, E., Sánchez-Escabias, E., Escaño‐Maestre, M., Ceballos-Chávez, M., & Reyes, J. C. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113855 · Cited by 33
A distal enhancer guides the negative selection of toxic glycoalkaloids during tomato domestication
Bai, F., Shu, P., Deng, H., Wu, Y., Chen, Y., Wu, M., Ma, T., Zhang, Y., Pirrello, J., Li, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47292-7 · Cited by 36
“…enhancer RNAs (eRNAs) are known to be transcribed from active enhancers and are associated to enhancer-promoter loops in regulating transcription 25 , we then performed PCR assays on WT and ws fruit tissues showing that GE1 RNA transcripts were successfully detected in WT and ws fruits at 7 DPA…”
MethodSelf-citationHorie, M., Yamaguchi, Y., Saito, A., Nagase, T., Lizio, M., Itoh, M., Kawaji, H., Lassmann, T., Carninci, P., Forrest, A. R. R., et al. (2016) · Scientific Reports · doi:10.1038/srep33666 · Cited by 33
Self-citationNoncoding RNA Surveillance: The Ends Justify the Means
Belair, C., Sim, S., & Wolin, S. L. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00462 · Cited by 30
Biophysically Motivated Regulatory Network Inference: Progress and Prospects
Äijö, T., & Bonneau, R. (2016) · Human Heredity · doi:10.1159/000446614 · Cited by 30
“…distal intergenic regulatory regions can reside megabases away from the affected gene; nevertheless, it has been demonstrated that the analysis of enhancer and promoter transcription patterns across numerous cell types and perturbations can be used to identify target gene and enhancer pairs [176] .”
BackgroundEmerging roles of noncoding RNAs in T cell differentiation and functions in autoimmune diseases
Roy, S., & Awasthi, A. (2019) · International Reviews of Immunology · doi:10.1080/08830185.2019.1648454 · Cited by 21
“lncRNAs (eRNAs) requires bidirectional transcription, capping, non-polyadenylation and non-splicing [18].”
BackgroundChromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells
Lindqvist, B., Akusjärvi, S. S., Sönnerborg, A. B., Dimitriou, M., & Svensson, J. P. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008264 · Cited by 34
“eRNAs are found at active enhancers and serve to maintain open chromatin and RNAPII occupancy [66].”
BackgroundPervasive and CpG-dependent promoter-like characteristics of transcribed enhancers
Steinhaus, R., Gonzalez, T., Seelow, D., & Robinson, P. N. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa223 · Cited by 30
“RNAPII transcribes so-called enhancer-derived RNAs (eR-NAs) bidirectionally from enhancer domains enriched in histone H3 monomethylated at lysine 4, i.e. H3K4me1 (12).”
InfluentialEnhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis
Odame, E., Chen, Y., Zheng, S., Dai, D., Kyei, B., Zhan, S., Cao, J., Guo, J., Zhong, T., Wang, L., et al. (2021) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-021-00248-x · Cited by 31
“Most eRNAs are usually unspliced and short, with an average size of 346 nucleotides [16].”
BackgroundSelf-citationUsing CRISPR to understand and manipulate gene regulation
Akıncı, E., Hamilton, M. C., Khowpinitchai, B., & Sherwood, R. I. (2021) · Development · doi:10.1242/dev.182667 · Cited by 37
Augmenting and directing long-range CRISPR-mediated activation in human cells
Tak, Y. E., Horng, J. E., Perry, N. T., Schultz, H. T., Iyer, S., Yao, Q., Zou, L. S., Aryee, M. J., Pinello, L., & Joung, J. K. (2021) · Nature Methods · doi:10.1038/s41592-021-01224-1 · Cited by 31
Extraordinary Cancer Epigenomics: Thinking Outside the Classical Coding and Promoter Box
Murtha, M. J., & Esteller, M. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.08.004 · Cited by 31
Takamochi, K., Mogushi, K., Kawaji, H., Imashimizu, K., Fukui, M., Oh, S., Itoh, M., Hayashizaki, Y., Ko, W., Akeboshi, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175622 · Cited by 33
Self-citationRodríguez, M. L., Kamińska, D., Lappalainen, K., Pihlajamäki, J., Kaikkonen, M. U., & Laakso, M. (2017) · Genome Medicine · doi:10.1186/s13073-017-0453-x · Cited by 33
Restrictor synergizes with Symplekin and PNUTS to terminate extragenic transcription
Russo, M., Piccolo, V., Polizzese, D., Prosperini, E., Borriero, C., Polletti, S., Bedin, F., Marenda, M., Michieletto, D., Mandana, G. M., et al. (2023) · Genes & Development · doi:10.1101/gad.351057.123 · Cited by 31
“…elements (enhancers and promoters) that provide modular platforms for the combinatorial binding of transcription factors (TFs) and the subsequent recruitment of RNA polymerase II (Pol II) (De Santa et al. 2010; Kim et al. 2010; Koch et al. 2011; Djebali et al. 2012; Andersson et al. 2014).”
BackgroundMehmood, F., Arshad, S., & Shoaib, M. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae030 · Cited by 31
“These eRNAs are identified through analyses like CAGE, enriching for active 5’ TSSs, or nascent transcript analyses like PRO-seq and GRO-seq, where transcript expression levels quantify enhancer activity functionally [24, 26–28].”
MethodMapping enhancer–gene regulatory interactions from single-cell data
Sheth, M. U., Qiu, W., Ma, X. R., Gschwind, A. R., Jagoda, E., Tan, A. S., Galante, J., Ray, J., Amgalan, D., Einarsson, H., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02695-8 · Cited by 45
Self-citationDecoding the non‐coding genome: elucidating genetic risk outside the coding genome
Barr, C. L., & Misener, V. L. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12269 · Cited by 30
“%) of disease-associated markers emerging from GWAS findings lie within the non-coding genome (Andersson et al. 2014; Farh et al. 2014; Maurano et al. 2012).”
BackgroundInfluentialNucleosome repositioning during differentiation of a human myeloid leukemia cell line
Teif, V. B., Mallm, J., Sharma, T., Welch, D. B. M., Rippe, K., Eils, R., Langowski, J., Olins, A. L., & Olins, D. E. (2017) · Nucleus · doi:10.1080/19491034.2017.1295201 · Cited by 28
Functional annotation of genomic variants in studies of late-onset Alzheimer’s disease
Butkiewicz, M., Blue, E., Leung, Y. Y., Jian, X., Marcora, E. M., Renton, A. E., Kuzma, A. B., Wang, L.-S., Koboldt, D. C., Haines, J. L., et al. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty177 · Cited by 30
Delgado-Vega, A. M., Martínez‐Bueno, M., Oparina, N. Y., Herráez, D. L., Kristjansdottir, H., Steinsson, K., Kozyrev, S. V., & Alarcón-Riquelme, M. E. (2018) · Scientific Reports · doi:10.1038/s41598-018-26274-y · Cited by 32
Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer
DeVaux, R. S., & Herschkowitz, J. I. (2018) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-018-9414-2 · Cited by 33
Nguyen, Q. H., Tellam, R. L., Naval-Sánchez, M., Porto-Neto, L. R., Barendse, W., Reverter, A., Hayes, B. J., Kijas, J., & Dalrymple, B. P. (2018) · GigaScience · doi:10.1093/gigascience/gix136 · Cited by 34
“The human Encyclopedia of DNA Elements (ENCODE), Functional Annotation of the Mammalian genome (FANTOM), Roadmap Epigenomics Mapping Consortium (ROADMAP), and related projects have generated large volumes of data relevant to the identification of promoters, enhancers, and other RDEs [6, 20, 21].”
InfluentialEnhancer Dysfunction in 3D Genome and Disease
Xia, J., & Wei, G. (2019) · Cells · doi:10.3390/cells8101281 · Cited by 28
“Most recently, the FANTOM5 project and results from recent studies showed that short bidirectional RNA is a signature for active enhancers and participates in looping for long-distance interactions [103].”
BackgroundQin, N., Ma, Z., Wang, C., Zhang, E., Li, Y., Huang, M., Chen, C., Zhang, C., Fan, J., Gu, Y., et al. (2020) · Theranostics · doi:10.7150/thno.47039 · Cited by 31
“We first obtained the genomic regions of 1,310,152 candidate regulatory elements defined by Chip-seq histone modification peaks from the ENCODE consortium (https://www.encodeproject. org/), and 65,423 active enhancers defined by the integration of chromatin modification, transcription factor binding, and CAGE-seq data…”
BackgroundInfluentialSalavati, M., Caulton, A., Clark, R. C., Gažová, I., Smith, T. P. L., Worley, K. C., Cockett, N. E., Archibald, A. L., Clarke, S., Murdoch, B. M., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.580580 · Cited by 33
“Though fewer in number these bi-directional (including TSS- enhancer) clusters are functionally important in the regulation of expression of their target genes (Andersson et al., 2014; Thodberg and Sandelin, 2019), consistent with finding them in over 2/3rds of tissues.”
BackgroundMethodRuiz, J. L., Ranford-Cartwright, L. C., & Gómez‐Díaz, E. (2021) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqaa113 · Cited by 38
“As a consequence, chromatin accessibility can be used as a proxy to globally identify active promoters and enhancers, and to predict gene activity (16,17).”
BackgroundEnhancer Pleiotropy, Gene Expression, and the Architecture of Human Enhancer–Gene Interactions
Singh, D., & Yi, S. V. (2021) · Molecular Biology and Evolution · doi:10.1093/molbev/msab085 · Cited by 31
“Analyses of the functionality of enhancer pleiotropy have the potential to reveal details of the enhancer–gene interaction architecture and its roles in evolution (Andersson et al. 2014; Fish et al. 2017; Sabar ıs et al. 2019).”
BackgroundTopological isolation of developmental regulators in mammalian genomes
Wu, H., Landshammer, A., Stamenova, E. K., Bolondi, A., Kretzmer, H., Meissner, A., & Michor, F. (2021) · Nature Communications · doi:10.1038/s41467-021-24951-7 · Cited by 36
Morgan, M. A., Shiekhattar, R., Shilatifard, A., & Lauberth, S. M. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.008 · Cited by 34
Limouse, C., Smith, O. K., Jukam, D., Fryer, K. A., Greenleaf, W. J., & Straight, A. F. (2023) · Nature Communications · doi:10.1038/s41467-023-41848-9 · Cited by 32
“Transcription of both lncRNAs 33,34 and regulatory elements 9,35 – 37 exhibits strong tissue speci fi city such that the ncRNA-Received gene interaction network is also likely cell-state dependent, although this remains to be experimentally tested.”
Scrutinizing the FTO locus: compelling evidence for a complex, long-range regulatory context
Rask‐Andersen, M., Almén, M. S., & Schiöth, H. B. (2015) · Human Genetics · doi:10.1007/s00439-015-1599-5 · Cited by 30
Interplay Between Genetic and Epigenetic Mechanisms in Rheumatoid Arthritis
Frank‐Bertoncelj, M., Klein, K., & Gay, S. (2017) · Epigenomics · doi:10.2217/epi-2016-0142 · Cited by 32
Putative enhancer sites in the bovine genome are enriched with variants affecting complex traits
Wang, M., Hancock, T., MacLeod, I. M., Pryce, J. E., Cocks, B. G., & Hayes, B. J. (2017) · Genetics Selection Evolution · doi:10.1186/s12711-017-0331-4 · Cited by 32
“VISTA [26], FANTOM5 [27], dbSUPER [28] and the Villar et al.”
BackgroundMethodGenome-wide profiling of transcribed enhancers during macrophage activation
Denisenko, E., Guler, R., Mhlanga, M. M., Suzuki, H., Brombacher, F., & Schmeier, S. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0158-9 · Cited by 31
“to infer enhancer regions as clusters of closely located bidirectional divergent CAGE peaks and to derive the corresponding tag counts [38].”
MethodInfluentialSelf-citationFast-Evolving Human-Specific Neural Enhancers Are Associated with Aging-Related Diseases
Chen, H., Li, C., Zhou, Z., & Liang, H. (2018) · Cell Systems · doi:10.1016/j.cels.2018.04.002 · Cited by 33
“The FANTOM project annotated the expression patterns of enhancers in the human genome (Andersson et al., 2014).”
InfluentialKorkmaz, G., Manber, Z., Lopes, R., Preković, S., Schuurman, K. G., Kim, Y., Teunissen, H., Flach, K. D., de Wit, E., Galli, G. G., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz675 · Cited by 29
“Building on eRNAs as a quantitative measure of enhancer activity (66), we used Global Run-On sequencing (GROseq) (67) to measure changes in nascent transcription in CBE1-knockout cells compared to control.”
MethodHigh-throughput annotation of full-length long noncoding RNAs with Capture Long-Read SequencingPreprint
Lagarde, J., Uszczyńska-Ratajczak, B., Carbonell, S., Pérez-Lluch, S., Abad, A., Davis, C., Gingeras, T., Frankish, A., Harrow, J., Guigó, R., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/105064 · Cited by 31
Recounting the FANTOM CAGE-Associated Transcriptome
Imada, E. L., Sanchez, D. F., Collado‐Torres, L., Wilks, C., Matam, T., Dinalankara, W., Stupnikov, A., Lobo, F. P., Yip, C.-W., Yasuzawa, K., et al. (2020) · Genome Research · doi:10.1101/gr.254656.119 · Cited by 36
“genomic coordinates from the FANTOM5 project (Andersson et al. 2014), identifying 4803 expressed genomic regions with prognos-”
BackgroundSelf-citationDissecting the cis-regulatory syntax of transcription initiation with deep learningPreprint
Cochran, K., Yin, M., Mantripragada, A., Schreiber, J. M., Marinov, G. K., Shah, S. R., Yu, H., Lis, J. T., & Kundaje, A. B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.28.596138 · Cited by 38
Epigenetic Regulation of Myeloid Cells
Ivashkiv, L. B., & Park, S. H. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0010-2015 · Cited by 29
“Finally, eRNAs have been shown to modulate the levels of nearby gene expression, potentially by facilitating enhancer-promoter interactions through chromatin looping, recruitment of cofactors, the release of the negative elongation factor complex (44, 62), and transcription-associated changes in histone marks.”
BackgroundFrequent hypermethylation of orphan CpG islands with enhancer activity in cancer
Bae, M. G., Kim, J. Y., & Choi, J. K. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0198-1 · Cited by 33
“Based on the fact that eRNAs are transcribed bidirectionally, active enhancers were detected using the bidirectional CAGE distribution through FANTOM5 [22].”
MethodEnhancer RNAs: Insights Into Their Biological Role
de Lara, J. C.-F., Arzate‐Mejía, R. G., & Targa, F. R. (2019) · Epigenetics Insights · doi:10.1177/2516865719846093 · Cited by 33
Song, W., Sharan, R., & Ovcharenko, I. (2019) · Genome Biology · doi:10.1186/s13059-019-1808-y · Cited by 28
The formation of the thumb requires direct modulation of Gli3 transcription by Hoxa13
Bastida, M. F., Pérez‐Gómez, R., Trofka, A., Zhu, J., Rada-Iglesias, Á., Sheth, R., Stadler, H. S., Mackem, S., & Ros, M. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919470117 · Cited by 27
“To evaluate whether Hox13 proteins can negatively regulate Gli3 expression through distal enhancer elements, we took advantage of the fact that enhancer activity positively correlates with the generation of short (50 to 2,000 nucleotides) bidirectional transcripts known as enhancer RNAs (eRNAs) (37).”
Locally acting transcription factors regulate p53-dependent cis-regulatory element activity
Catizone, A. N., Uzunbas, G. K., Celadova, P., Kuang, S., Bose, D. A., & Sammons, M. A. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa147 · Cited by 28
Gerrard, D. T., Berry, A. A., Jennings, R. E., Birket, M. J., Zarrineh, P., Garstang, M. G., Withey, S., Short, P., Jiménez-Gancedo, S., Firbas, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17305-2 · Cited by 29
The epitranscriptome of long noncoding RNAs in metabolic diseases
Yin, L., Zhu, X., Novák, P., Zhou, L., Gao, L., Yang, M., Zhao, G., & Yin, K. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.001 · Cited by 29
Yousefi, S., Deng, R., Lanko, K., Salsench, E. M., Nikoncuk, A., van der Linde, H. C., Perenthaler, E., van Ham, T. J., Mulugeta, E., & Barakat, T. S. (2021) · Genome Medicine · doi:10.1186/s13073-021-00980-1 · Cited by 32
“Large scale community driven efforts [7-11] and a plethora of individual studies have produced a vast amount of epigenome data sets, such as profiles of histone modifications, chromatin accessibility and chromatin interactions for different human tissues and cell types, that can be used to predict putative enhancers a…”
BackgroundMethodHaswell, J. R., Mattioli, K., Gerhardinger, C., Maass, P. G., Foster, D. J., Peinado, P., Wang, X., Medina, P. P., Rinn, J. L., & Slack, F. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252848 · Cited by 32
Metadata
- Authors
- The FANTOM Consortium, Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., Ntini, E., Arner, E., Valen, E., Li, K., Schwarzfischer, L., Glatz, D., Raithel, J., Lilje, B., Rapin, N., Bagger, F. O., Jørgensen, M., Andersen, P. R., Bertin, N., Rackham, O., Burroughs, A. M., Baillie, J. K., Ishizu, Y., Shimizu, Y., Furuhata, E., Maeda, S., Negishi, Y., Mungall, C. J., Meehan, T. F., Lassmann, T., Itoh, M., Kawaji, H., Kondo, N., Kawai, J., Lennartsson, A., Daub, C. O., Heutink, P., Hume, D. A., Jensen, T. H., Suzuki, H., Hayashizaki, Y., Müller, F., Forrest, A. R. R., Carninci, P., Rehli, M., & Sandelin, A.
- Affiliations
- University of Copenhagen (DK)
- University Hospital Regensburg (DE)
- University of Birmingham (GB)
- University of North Carolina at Chapel Hill (US)
- RIKEN (JP)
- Aarhus University (DK)
- Roslin Institute (GB)
- European Bioinformatics Institute (GB)
- Karolinska Institutet (SE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Corresponding author
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- ORCID
- Andersson, Robin
- Gebhard, Claudia
- Miguel-Escalada, Irene
- Hoof, Ilka
- Bornholdt, Jette
- Chen, Yun
- Schmidl, Christian
- Suzuki, Takahiro
- Ntini, Evgenia
- Valen, Eivind
- Li, Kang
- Lilje, Berit
- Rapin, Nicolas
- Bagger, Frederik Otzen
- Andersen, Peter Refsing
- Bertin, Nicolas
- Rackham, Owen
- Burroughs, A. Maxwell
- Baillie, J. Kenneth
- Ishizu, Yuri
- Shimizu, Yuri
- Furuhata, Erina
- Meehan, Terrence F.
- Lassmann, Timo
- Itoh, Masayoshi
- Kawaji, Hideya
- Kawai, Jun
- Lennartsson, Andreas
- Daub, Carsten O.
- Heutink, Peter
- Hume, David A.
- Jensen, Torben Heick
- Suzuki, Harukazu
- Hayashizaki, Yoshihide
- Müller, Ferenc
- Forrest, Alistair R. R.
- Carninci, Piero
- Rehli, Michael
- Sandelin, Albin
- Venue
- Nature
- Published
- 2014-03
- Volume
- 507
- Issue
- 7493
- Pages
- 455-461
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5215096
- OpenAlex
- W2015845481
- Cited by
- 2,550
- References
- 81
- Citations by year
- 2026: 93 · 2025: 140 · 2024: 207 · 2023: 185 · 2022: 225 · 2021: 280 · 2020: 232 · 2019: 226 · 2018: 261 · 2017: 208 · 2016: 186 · 2015: 212 · 2014: 89
- FWCI
- 95.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion)
- PubMed Central (acceptedVersion)
- SDL (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Griffith Research Online (submittedVersion)
- Funders
- Wellcome Trust (103258/Z/13/Z)
- European Commission (FP7/2007–2013/ERC, 2007–2013, FP7 2007-2013, FP7/2007)
- Deutsche Forschungsgemeinschaft (FP7/2007–2013)
- Ministry of Education, Culture, Sports, Science and Technology
- Lundbeckfonden (R167-2013-15058, R82-2010-6779)
- Novo Nordisk
- Novo Nordisk Fonden (NNF12OC0001211)
- H. Lundbeck A/S
- Biotechnology and Biological Sciences Research Council (BBS/E/D/20251969, BB/I024801/1)
- Japan Society for the Promotion of Science (24659373, 25330333, 22228005)
- RIKEN
- National Institute of Dental and Craniofacial Research (R01DE022969)
- FP7 Ideas: European Research Council (204135)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- enhancers, bidirectional transcription, unspliced RNA, FANTOM5, CAGE, cell type-specific gene regulation, regulatory single nucleotide polymorphisms, enhancer redundancy, transcription start sites, promoter usage, human cell types, tissue-specific enhancers
- MeSH terms
- Atlases as Topic, Cell Line, Cells, Cultured, Enhancer Elements, Genetic, Gene Expression Regulation, HeLa Cells, Humans, Organ Specificity, Promoter Regions, Genetic, RNA, Messenger, Cluster Analysis, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Transcription Initiation Site, Molecular Sequence Annotation, Transcription Initiation, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.